Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man.
Riess
F C
FC
Department of Cardiac Surgery, Albertinen-Krankenhaus, Hamburg, Germany.
Löwer
C
C
Seelig
C
C
Bleese
N
N
Kormann
J
J
Müller-Berghaus
G
G
Pötzsch
B
B
D000368:Aged; D001021:Aortic Valve / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis; D001792:Blood Platelets / Q000187:drug effects; D002315:Cardiopulmonary Bypass; D005260:Female; D006350:Heart Valve Prosthesis; D006493:Heparin / Q000008:administration & dosage; D024764:Hirudin Therapy; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D006493:Heparin